| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Human | 27 | 2018 | 1255 | 2.580 |
Why?
|
| Software | 18 | 2023 | 669 | 2.550 |
Why?
|
| Epigenomics | 8 | 2016 | 160 | 2.310 |
Why?
|
| Epigenesis, Genetic | 14 | 2021 | 659 | 2.060 |
Why?
|
| DNA Methylation | 16 | 2023 | 971 | 2.030 |
Why?
|
| Extracellular Vesicles | 6 | 2023 | 45 | 1.490 |
Why?
|
| Metabolomics | 3 | 2022 | 388 | 1.350 |
Why?
|
| Sequence Analysis, DNA | 20 | 2018 | 1759 | 1.200 |
Why?
|
| Genome | 13 | 2012 | 471 | 1.160 |
Why?
|
| Genetic Variation | 14 | 2023 | 1460 | 1.110 |
Why?
|
| Disease | 3 | 2018 | 129 | 1.050 |
Why?
|
| Algorithms | 8 | 2021 | 1569 | 1.030 |
Why?
|
| Computational Biology | 11 | 2020 | 790 | 0.940 |
Why?
|
| Breast Neoplasms | 4 | 2023 | 2478 | 0.900 |
Why?
|
| Gene Regulatory Networks | 5 | 2018 | 352 | 0.840 |
Why?
|
| Evolution, Molecular | 13 | 2015 | 670 | 0.810 |
Why?
|
| Information Theory | 1 | 2021 | 4 | 0.750 |
Why?
|
| MicroRNAs | 7 | 2020 | 836 | 0.730 |
Why?
|
| Genes, Neoplasm | 2 | 2013 | 79 | 0.720 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 129 | 0.720 |
Why?
|
| RNA | 5 | 2023 | 577 | 0.700 |
Why?
|
| Databases, Genetic | 10 | 2024 | 467 | 0.690 |
Why?
|
| Gene Expression Profiling | 6 | 2023 | 1675 | 0.680 |
Why?
|
| Genomic Instability | 4 | 2014 | 230 | 0.660 |
Why?
|
| Allelic Imbalance | 1 | 2018 | 11 | 0.630 |
Why?
|
| Cell Communication | 1 | 2019 | 165 | 0.610 |
Why?
|
| Glioblastoma | 2 | 2020 | 322 | 0.600 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2023 | 2511 | 0.550 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 353 | 0.540 |
Why?
|
| Endothelial Cells | 1 | 2020 | 528 | 0.530 |
Why?
|
| DNA | 11 | 2015 | 1606 | 0.530 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2023 | 864 | 0.510 |
Why?
|
| Macaca mulatta | 6 | 2011 | 494 | 0.510 |
Why?
|
| Mutation Rate | 2 | 2013 | 66 | 0.500 |
Why?
|
| Glioma | 1 | 2020 | 467 | 0.500 |
Why?
|
| Cell Differentiation | 4 | 2021 | 1933 | 0.500 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 258 | 0.500 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 374 | 0.500 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2015 | 31 | 0.490 |
Why?
|
| Humans | 77 | 2024 | 121793 | 0.480 |
Why?
|
| Metagenomics | 2 | 2012 | 109 | 0.480 |
Why?
|
| Cell-Free Nucleic Acids | 3 | 2019 | 43 | 0.470 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 465 | 0.470 |
Why?
|
| Sequence Alignment | 5 | 2014 | 623 | 0.450 |
Why?
|
| Mutation | 8 | 2017 | 5773 | 0.440 |
Why?
|
| Chromosome Mapping | 7 | 2014 | 1064 | 0.440 |
Why?
|
| Smoking | 1 | 2019 | 1018 | 0.430 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2013 | 26 | 0.430 |
Why?
|
| Neoplasms | 6 | 2023 | 2697 | 0.430 |
Why?
|
| Oncogene Fusion | 1 | 2013 | 22 | 0.430 |
Why?
|
| Chromosome Aberrations | 3 | 2011 | 614 | 0.430 |
Why?
|
| DNA Copy Number Variations | 3 | 2013 | 941 | 0.420 |
Why?
|
| RNA, Long Noncoding | 1 | 2015 | 209 | 0.400 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 535 | 0.400 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2012 | 374 | 0.380 |
Why?
|
| CpG Islands | 9 | 2018 | 313 | 0.380 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 3297 | 0.370 |
Why?
|
| Brain | 3 | 2020 | 2941 | 0.360 |
Why?
|
| Base Sequence | 11 | 2015 | 3117 | 0.360 |
Why?
|
| Nucleic Acid Hybridization | 4 | 2010 | 397 | 0.350 |
Why?
|
| Gene Dosage | 2 | 2011 | 441 | 0.340 |
Why?
|
| Chromosome Breakage | 2 | 2008 | 168 | 0.320 |
Why?
|
| Pre-Eclampsia | 2 | 2021 | 219 | 0.320 |
Why?
|
| Genomics | 9 | 2023 | 1467 | 0.320 |
Why?
|
| Metabolome | 2 | 2021 | 290 | 0.310 |
Why?
|
| Alleles | 5 | 2018 | 1585 | 0.310 |
Why?
|
| Gene Rearrangement | 4 | 2015 | 323 | 0.310 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2015 | 194 | 0.300 |
Why?
|
| Chromosomes, Artificial, Bacterial | 6 | 2008 | 93 | 0.290 |
Why?
|
| Metagenome | 3 | 2012 | 150 | 0.270 |
Why?
|
| Research Design | 3 | 2013 | 645 | 0.270 |
Why?
|
| Animals | 33 | 2023 | 33870 | 0.260 |
Why?
|
| Computer Simulation | 5 | 2020 | 609 | 0.260 |
Why?
|
| Hylobates | 3 | 2012 | 10 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 1881 | 0.230 |
Why?
|
| Data Mining | 2 | 2022 | 53 | 0.230 |
Why?
|
| Physical Chromosome Mapping | 1 | 2004 | 56 | 0.230 |
Why?
|
| Microsatellite Repeats | 4 | 2008 | 218 | 0.230 |
Why?
|
| Genome-Wide Association Study | 5 | 2023 | 1587 | 0.230 |
Why?
|
| Flow Cytometry | 2 | 2023 | 808 | 0.220 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 2792 | 0.210 |
Why?
|
| Cell-Derived Microparticles | 1 | 2023 | 31 | 0.210 |
Why?
|
| Sulfites | 3 | 2018 | 30 | 0.210 |
Why?
|
| Exosomes | 1 | 2023 | 41 | 0.210 |
Why?
|
| Publications | 1 | 2022 | 31 | 0.210 |
Why?
|
| Homologous Recombination | 2 | 2013 | 93 | 0.200 |
Why?
|
| Germ Cells | 2 | 2014 | 185 | 0.200 |
Why?
|
| Databases, Factual | 4 | 2023 | 1155 | 0.200 |
Why?
|
| Quantitative Trait Loci | 1 | 2023 | 263 | 0.200 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2022 | 93 | 0.190 |
Why?
|
| Sex Differentiation | 1 | 2021 | 22 | 0.190 |
Why?
|
| Computer Graphics | 1 | 2021 | 37 | 0.190 |
Why?
|
| Phenotype | 5 | 2023 | 4200 | 0.180 |
Why?
|
| Pan troglodytes | 5 | 2007 | 70 | 0.180 |
Why?
|
| Ovarian Neoplasms | 2 | 2015 | 412 | 0.180 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 87 | 0.180 |
Why?
|
| Synteny | 4 | 2015 | 74 | 0.180 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 2539 | 0.180 |
Why?
|
| Cellular Senescence | 1 | 2021 | 158 | 0.170 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 137 | 0.170 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 1993 | 368 | 0.170 |
Why?
|
| Gastrointestinal Tract | 2 | 2012 | 207 | 0.170 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2012 | 576 | 0.170 |
Why?
|
| Aspirin | 1 | 2021 | 221 | 0.170 |
Why?
|
| Organ Specificity | 3 | 2015 | 427 | 0.170 |
Why?
|
| Cell Line | 2 | 2023 | 2787 | 0.170 |
Why?
|
| Female | 19 | 2023 | 64573 | 0.170 |
Why?
|
| Circulating MicroRNA | 1 | 2019 | 8 | 0.160 |
Why?
|
| Electronic Health Records | 2 | 2016 | 690 | 0.160 |
Why?
|
| Antigens, Ly | 1 | 2019 | 32 | 0.160 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2012 | 206 | 0.160 |
Why?
|
| CTLA-4 Antigen | 1 | 2019 | 50 | 0.160 |
Why?
|
| Genetic Loci | 2 | 2018 | 332 | 0.160 |
Why?
|
| Body Fluids | 1 | 2019 | 48 | 0.160 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2019 | 36 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 240 | 0.160 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 94 | 0.160 |
Why?
|
| Phylogeny | 3 | 2012 | 684 | 0.160 |
Why?
|
| Embryonic Stem Cells | 3 | 2015 | 172 | 0.160 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2019 | 78 | 0.150 |
Why?
|
| User-Computer Interface | 2 | 2016 | 151 | 0.150 |
Why?
|
| Adipose Tissue | 2 | 2021 | 444 | 0.150 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 105 | 0.150 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 104 | 0.150 |
Why?
|
| Polymorphism, Genetic | 4 | 2008 | 800 | 0.150 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 900 | 0.140 |
Why?
|
| Species Specificity | 5 | 2011 | 552 | 0.140 |
Why?
|
| Search Engine | 2 | 2016 | 5 | 0.140 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2024 | 445 | 0.140 |
Why?
|
| Information Dissemination | 1 | 2018 | 186 | 0.130 |
Why?
|
| Gene Ontology | 1 | 2016 | 48 | 0.130 |
Why?
|
| Histones | 3 | 2015 | 528 | 0.130 |
Why?
|
| Biomarkers | 3 | 2021 | 2926 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 992 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 400 | 0.130 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 518 | 0.130 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 3886 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 444 | 0.130 |
Why?
|
| Binding Sites | 1 | 2018 | 1294 | 0.130 |
Why?
|
| Laboratories | 1 | 2016 | 83 | 0.130 |
Why?
|
| Polycomb-Group Proteins | 1 | 2015 | 18 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2016 | 296 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2012 | 240 | 0.120 |
Why?
|
| Exome | 3 | 2018 | 1034 | 0.120 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 36 | 0.120 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 135 | 0.120 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2015 | 47 | 0.120 |
Why?
|
| Mice | 11 | 2023 | 17624 | 0.120 |
Why?
|
| Transcriptome | 1 | 2021 | 906 | 0.120 |
Why?
|
| Pharmacogenetics | 1 | 2015 | 178 | 0.120 |
Why?
|
| DNA, Mitochondrial | 2 | 2014 | 211 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2014 | 5 | 0.120 |
Why?
|
| Base Composition | 5 | 2013 | 72 | 0.110 |
Why?
|
| Centromere | 2 | 2012 | 107 | 0.110 |
Why?
|
| Genetic Markers | 2 | 2006 | 590 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2019 | 655 | 0.110 |
Why?
|
| Carcinogenesis | 1 | 2016 | 335 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 3 | 2016 | 201 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1993 | 287 | 0.110 |
Why?
|
| Genetic Testing | 2 | 2018 | 988 | 0.110 |
Why?
|
| DNA Transposable Elements | 2 | 2012 | 179 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2011 | 204 | 0.110 |
Why?
|
| Precision Medicine | 3 | 2024 | 306 | 0.100 |
Why?
|
| Gene Fusion | 1 | 2013 | 55 | 0.100 |
Why?
|
| Cytosine | 2 | 2010 | 56 | 0.100 |
Why?
|
| Models, Genetic | 2 | 2013 | 740 | 0.100 |
Why?
|
| Haplotypes | 1 | 2014 | 507 | 0.100 |
Why?
|
| Biomedical Research | 2 | 2016 | 508 | 0.100 |
Why?
|
| Rats | 4 | 2004 | 3659 | 0.100 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2012 | 81 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 492 | 0.100 |
Why?
|
| Transcription Factors | 3 | 2018 | 2580 | 0.100 |
Why?
|
| Mixed Function Oxygenases | 1 | 2011 | 34 | 0.100 |
Why?
|
| Prognosis | 2 | 2019 | 4438 | 0.100 |
Why?
|
| Finches | 1 | 2011 | 6 | 0.100 |
Why?
|
| Vocalization, Animal | 1 | 2011 | 17 | 0.100 |
Why?
|
| Male | 14 | 2021 | 59243 | 0.100 |
Why?
|
| Prosencephalon | 1 | 2011 | 40 | 0.090 |
Why?
|
| Knowledge Bases | 2 | 2023 | 36 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 551 | 0.090 |
Why?
|
| Auditory Cortex | 1 | 2011 | 30 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 750 | 0.090 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2011 | 53 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 2009 | 0.090 |
Why?
|
| Chromosome Disorders | 1 | 2013 | 310 | 0.090 |
Why?
|
| Adult | 7 | 2021 | 28549 | 0.090 |
Why?
|
| Heart Failure | 1 | 2023 | 2125 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 301 | 0.090 |
Why?
|
| Vagina | 1 | 2012 | 202 | 0.090 |
Why?
|
| Disease Progression | 1 | 2016 | 1984 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2011 | 138 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2012 | 227 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1590 | 0.090 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 129 | 0.090 |
Why?
|
| Interleukin-13 | 1 | 2010 | 95 | 0.090 |
Why?
|
| Guidelines as Topic | 3 | 2017 | 194 | 0.090 |
Why?
|
| Genetic Techniques | 2 | 2007 | 102 | 0.080 |
Why?
|
| Genetic Engineering | 1 | 2010 | 161 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 216 | 0.080 |
Why?
|
| Locus Control Region | 1 | 2008 | 8 | 0.080 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2008 | 16 | 0.080 |
Why?
|
| Microbiota | 1 | 2014 | 392 | 0.080 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 11 | 0.080 |
Why?
|
| Callithrix | 1 | 2008 | 9 | 0.080 |
Why?
|
| Probability | 2 | 2004 | 318 | 0.080 |
Why?
|
| Exons | 1 | 2011 | 793 | 0.080 |
Why?
|
| Testis | 1 | 2010 | 401 | 0.080 |
Why?
|
| Contig Mapping | 2 | 2006 | 55 | 0.080 |
Why?
|
| Cluster Analysis | 2 | 2012 | 384 | 0.080 |
Why?
|
| Models, Statistical | 1 | 2011 | 446 | 0.080 |
Why?
|
| Trinucleotide Repeats | 1 | 2008 | 109 | 0.080 |
Why?
|
| Autistic Disorder | 1 | 2011 | 345 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2011 | 1463 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 268 | 0.070 |
Why?
|
| Ovary | 1 | 2010 | 390 | 0.070 |
Why?
|
| Strongylocentrotus purpuratus | 1 | 2006 | 5 | 0.070 |
Why?
|
| Papio hamadryas | 1 | 2006 | 1 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2011 | 501 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2021 | 4518 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 83 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2006 | 92 | 0.060 |
Why?
|
| Genetics, Population | 1 | 2006 | 185 | 0.060 |
Why?
|
| DNA Repair | 1 | 2008 | 580 | 0.060 |
Why?
|
| Chromosomes, Human | 2 | 2015 | 130 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 1280 | 0.060 |
Why?
|
| Rats, Inbred BN | 1 | 2004 | 16 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2012 | 759 | 0.060 |
Why?
|
| Molecular Sequence Annotation | 2 | 2016 | 144 | 0.060 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 263 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 1437 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2023 | 136 | 0.050 |
Why?
|
| Reference Standards | 2 | 2016 | 239 | 0.050 |
Why?
|
| Asthma | 1 | 2010 | 742 | 0.050 |
Why?
|
| PubMed | 1 | 2022 | 21 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2021 | 3075 | 0.050 |
Why?
|
| Translocation, Genetic | 2 | 2015 | 352 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 2 | 1993 | 112 | 0.050 |
Why?
|
| Pregnancy | 3 | 2021 | 7045 | 0.050 |
Why?
|
| Obesity | 1 | 2012 | 1938 | 0.050 |
Why?
|
| Embryonal Carcinoma Stem Cells | 1 | 2021 | 10 | 0.050 |
Why?
|
| Embryonic Germ Cells | 1 | 2021 | 9 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2023 | 338 | 0.050 |
Why?
|
| Dasatinib | 1 | 2021 | 42 | 0.050 |
Why?
|
| Multigene Family | 2 | 2007 | 298 | 0.050 |
Why?
|
| Spermatogonia | 1 | 2021 | 29 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 97 | 0.050 |
Why?
|
| DNA, Complementary | 2 | 2006 | 465 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 1007 | 0.050 |
Why?
|
| Models, Econometric | 1 | 2000 | 9 | 0.050 |
Why?
|
| Patents as Topic | 1 | 2000 | 19 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 788 | 0.040 |
Why?
|
| Teratoma | 1 | 2021 | 125 | 0.040 |
Why?
|
| Internet | 2 | 2012 | 367 | 0.040 |
Why?
|
| Drug Design | 1 | 2000 | 147 | 0.040 |
Why?
|
| Child | 3 | 2019 | 23789 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 1582 | 0.040 |
Why?
|
| Mitochondria | 1 | 2023 | 679 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2023 | 618 | 0.040 |
Why?
|
| Urea | 1 | 2019 | 210 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 179 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 1351 | 0.040 |
Why?
|
| Karyotyping | 2 | 2009 | 338 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 324 | 0.040 |
Why?
|
| Gestational Age | 1 | 2021 | 1108 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 519 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 569 | 0.040 |
Why?
|
| Web Browser | 1 | 2016 | 8 | 0.030 |
Why?
|
| Expressed Sequence Tags | 2 | 2006 | 78 | 0.030 |
Why?
|
| Genetics, Medical | 1 | 2017 | 117 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 999 | 0.030 |
Why?
|
| Genes | 2 | 2006 | 443 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2016 | 124 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 107 | 0.030 |
Why?
|
| Gene Library | 1 | 1996 | 220 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 1996 | 184 | 0.030 |
Why?
|
| Mathematics | 1 | 1995 | 97 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2015 | 84 | 0.030 |
Why?
|
| Histone Code | 1 | 2015 | 52 | 0.030 |
Why?
|
| Kidney | 1 | 2021 | 1343 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 2997 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2321 | 0.030 |
Why?
|
| Gene Duplication | 2 | 2007 | 358 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 1993 | 18 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 620 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 693 | 0.030 |
Why?
|
| Fallopian Tubes | 1 | 2014 | 72 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2015 | 297 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 1993 | 45 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 43 | 0.030 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2013 | 57 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2015 | 347 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2015 | 459 | 0.030 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2012 | 20 | 0.030 |
Why?
|
| YY1 Transcription Factor | 1 | 2012 | 12 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 1076 | 0.030 |
Why?
|
| Chromosome Painting | 1 | 2012 | 16 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 36 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 1318 | 0.030 |
Why?
|
| Primates | 1 | 1992 | 80 | 0.030 |
Why?
|
| Chromosome Duplication | 1 | 2013 | 146 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2015 | 249 | 0.030 |
Why?
|
| Autopsy | 1 | 2012 | 115 | 0.020 |
Why?
|
| DNA Repeat Expansion | 1 | 2012 | 61 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 668 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 270 | 0.020 |
Why?
|
| Ruminococcus | 1 | 2011 | 11 | 0.020 |
Why?
|
| Haemophilus parainfluenzae | 1 | 2011 | 11 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2012 | 293 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2012 | 88 | 0.020 |
Why?
|
| Chromatin | 1 | 2015 | 550 | 0.020 |
Why?
|
| DNA Probes | 1 | 2011 | 125 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2012 | 212 | 0.020 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2011 | 55 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 87 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1616 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 160 | 0.020 |
Why?
|
| India | 1 | 2011 | 218 | 0.020 |
Why?
|
| Nucleotides | 1 | 2010 | 92 | 0.020 |
Why?
|
| Meiosis | 1 | 2010 | 115 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 255 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2700 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 481 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 524 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 636 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2010 | 163 | 0.020 |
Why?
|
| X Chromosome | 1 | 2010 | 339 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 697 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 715 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 6168 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 26 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 1073 | 0.020 |
Why?
|
| Alu Elements | 1 | 2009 | 64 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 2008 | 37 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2011 | 308 | 0.020 |
Why?
|
| Base Pairing | 1 | 2008 | 43 | 0.020 |
Why?
|
| United States | 2 | 2016 | 10413 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2829 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1272 | 0.020 |
Why?
|
| Bacteria | 1 | 2012 | 483 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2008 | 69 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 184 | 0.020 |
Why?
|
| Temperature | 1 | 2008 | 304 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1231 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2006 | 22 | 0.020 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2006 | 17 | 0.020 |
Why?
|
| Complement Activation | 1 | 2006 | 52 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1414 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 1007 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 19 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 1113 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2006 | 55 | 0.020 |
Why?
|
| Chromosome Inversion | 1 | 2006 | 76 | 0.020 |
Why?
|
| Stem Cells | 1 | 2010 | 710 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1520 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 226 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 147 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2006 | 178 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 305 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 8676 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2006 | 208 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 3132 | 0.010 |
Why?
|
| Chromosomes, Mammalian | 1 | 2004 | 42 | 0.010 |
Why?
|
| Retroelements | 1 | 2004 | 41 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 15794 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2004 | 87 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 2962 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2006 | 373 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2006 | 528 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 167 | 0.010 |
Why?
|
| RNA, Untranslated | 1 | 2004 | 114 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 13661 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 301 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 1393 | 0.010 |
Why?
|
| Pedigree | 1 | 2006 | 1574 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 354 | 0.010 |
Why?
|
| Telomere | 1 | 2004 | 205 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 6275 | 0.010 |
Why?
|
| Proteins | 1 | 2006 | 1039 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 4385 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 18773 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2004 | 1069 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 4306 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 737 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 18732 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 25516 | 0.010 |
Why?
|